NASDAQ:ACMRACM Research Stock Price, Forecast & News

ACM Research's stock was trading at $25.60 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ACMR shares have increased by 106.5% and is now trading at $52.87. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ACM Research in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for ACM Research.

ACM Research is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for ACM Research.

ACM Research Inc (NASDAQ:ACMR) released its earnings results on Wednesday, May, 6th. The specialty retailer reported $0.11 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.02 by $0.09. The specialty retailer had revenue of $24.35 million for the quarter, compared to the consensus estimate of $19.95 million. ACM Research had a return on equity of 25.64% and a net margin of 16.83%. View ACM Research's earnings history.

ACM Research updated its FY 2020 After-Hours earnings guidance on Wednesday, May, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $130-150 million, compared to the consensus revenue estimate of $138.58 million.

7 Wall Street analysts have issued twelve-month price objectives for ACM Research's stock. Their forecasts range from $31.00 to $80.00. On average, they anticipate ACM Research's share price to reach $53.86 in the next twelve months. This suggests a possible upside of 1.9% from the stock's current price. View analysts' price targets for ACM Research.

News stories about ACMR stock have been trending negative recently, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ACM Research earned a coverage optimism score of -2.0 on InfoTrie's scale. They also gave media coverage about the specialty retailer a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutACM Research.

ACM Research saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 1,280,000 shares, a decline of 7.2% from the April 30th total of 1,380,000 shares. Based on an average daily trading volume, of 560,500 shares, the short-interest ratio is currently 2.3 days. Approximately 11.3% of the shares of the stock are sold short. View ACM Research's Current Options Chain.

Some companies that are related to ACM Research include Brooks Automation (BRKS), IHI CORP/ADR (IHICY), Bodycote (BYPLF), Axcelis Technologies (ACLS), Veeco Instruments (VECO), Energy Recovery (ERII), Intevac (IVAC), Manitex International (MNTX), Amtech Systems (ASYS), CVD Equipment (CVV), Taronis Technologies (TRNX), Enviro Technologies (EVTN) and Greystone Logistics (GLGI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other ACM Research investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Walt Disney (DIS), Crispr Therapeutics (CRSP), Micron Technology (MU), Square (SQ), salesforce.com (CRM), Roku (ROKU) and Tesla (TSLA).

(ACMR) raised $17 million in an initial public offering (IPO) on Friday, November 3rd 2017. The company issued 2,000,000 shares at a price of $7.50-$9.50 per share. Roth Capital Partners served as the underwriter for the IPO and Craig-Hallum Capital Group and The Benchmark Company were co-managers.

ACM Research trades on the NASDAQ under the ticker symbol "ACMR."

ACM Research's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Invesco Ltd. (1.47%), BlackRock Inc. (1.33%), EAM Investors LLC (0.56%), Geode Capital Management LLC (0.52%), Calamos Advisors LLC (0.48%) and Nomura Holdings Inc. (0.48%).

ACMR stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Deutsche Bank AG, Globeflex Capital L P, Calamos Advisors LLC, WINTON GROUP Ltd, Bank of New York Mellon Corp, and State Street Corp.

ACMR stock was acquired by a variety of institutional investors in the last quarter, including Invesco Ltd., Nomura Holdings Inc., EAM Investors LLC, EAM Global Investors LLC, Oasis Management Co Ltd., Pinpoint Asset Management Ltd, Parametric Portfolio Associates LLC, and KEYWISE CAPITAL MANAGEMENT HK Ltd.

Shares of ACMR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ACMR stock can currently be purchased for approximately $52.87.

ACM Research has a market capitalization of $863.21 million and generates $107.52 million in revenue each year. The specialty retailer earns $18.89 million in net income (profit) each year or $1.17 on an earnings per share basis. ACM Research employs 273 workers across the globe.

The official website for ACM Research is www.acmrcsh.com.

ACM Research's mailing address is 42307 OSGOOD ROAD SUITE I, FREMONT CA, 94539. The specialty retailer can be reached via phone at 510-445-3700 or via email at [email protected]